Capecitabina Mylan

Capecitabine Mylan is an oral medication used in cancer treatment. It belongs to a class of drugs known as antimetabolites, which interfere with the growth of cancer cells.

Capecitabine Mylan is primarily used in the treatment of certain types of cancer, including colorectal cancer and breast cancer. It works by slowing or stopping the growth of cancer cells. The medication is often prescribed as part of a combination therapy, depending on the specific type and stage of cancer.

Common effects of Capecitabine Mylan may include nausea, vomiting, diarrhea, and hand-foot syndrome, which is characterized by redness, swelling, and peeling of the skin on the palms of the hands and soles of the feet. Some individuals may also experience fatigue and loss of appetite.

Capecitabine Mylan should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should be aware of potential side effects and report any severe or persistent symptoms to their healthcare provider.

Capecitabine Mylan may interact with other medications, including blood thinners, certain pain relievers, and other cancer treatments. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare professional.